BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 20548266)

  • 21. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update.
    Gjertson DW
    Clin Transpl; 1996; ():343-60. PubMed ID: 9286581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Race effects.
    Koyama H; Cecka JM
    Clin Transpl; 1991; ():269-80. PubMed ID: 1820122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation.
    Heise ER; Thacker LR; MacQueen JM; Peters TG
    Clin Transplant; 1996 Dec; 10(6 Pt 2):579-85. PubMed ID: 8996746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
    Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
    Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age on kidney transplants.
    Zhou YC; Cecka JM
    Clin Transpl; 1989; ():369-78. PubMed ID: 2487605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium.
    Sirchia G; Poli F; Cardillo M; Scalamogna M; Rebulla P; Taioli E; Remuzzi G; Nocera A
    Clin Transpl; 1998; ():133-45. PubMed ID: 10503092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney transplantation using expanded criteria donors in Korea.
    Jeong JC; Kim MG; Ro H; Kim YJ; Park HC; Kwon HY; Jeon HJ; Ha J; Ahn C; Yang J
    Transplant Proc; 2012 Jan; 44(1):54-6. PubMed ID: 22310577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study.
    Opelz G; Wujciak T
    N Engl J Med; 1994 Mar; 330(12):816-9. PubMed ID: 8068075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage.
    Aydingoz SE; Takemoto SK; Pinsky BW; Salvalaggio PR; Lentine KL; Willoughby L; Hoover B; Burroughs TA; Schnitzler MA; Graff R
    Hum Immunol; 2007 Jun; 68(6):491-9. PubMed ID: 17509448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.